MXPA05013958A - Tratamiento de cancer con epotilona. - Google Patents
Tratamiento de cancer con epotilona.Info
- Publication number
- MXPA05013958A MXPA05013958A MXPA05013958A MXPA05013958A MXPA05013958A MX PA05013958 A MXPA05013958 A MX PA05013958A MX PA05013958 A MXPA05013958 A MX PA05013958A MX PA05013958 A MXPA05013958 A MX PA05013958A MX PA05013958 A MXPA05013958 A MX PA05013958A
- Authority
- MX
- Mexico
- Prior art keywords
- epothilones
- cancer treatment
- administration
- treatment
- epotilone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
El uso de una epotilona para el tratamiento de una enfermedad proliferativa, el cual comprende el paso de administrar diariamente una cantidad terapeuticamente efectiva de una epotilona mediante administracion intravenosa (i.v.) continua.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48326303P | 2003-06-27 | 2003-06-27 | |
PCT/EP2004/006921 WO2005000292A1 (en) | 2003-06-27 | 2004-06-25 | Cancer treatment with epothilones |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05013958A true MXPA05013958A (es) | 2006-02-24 |
Family
ID=33552048
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05013958A MXPA05013958A (es) | 2003-06-27 | 2004-06-25 | Tratamiento de cancer con epotilona. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20060205795A1 (es) |
EP (1) | EP1641449A1 (es) |
JP (1) | JP2009513486A (es) |
CN (1) | CN1812780A (es) |
AU (1) | AU2004251444B2 (es) |
BR (1) | BRPI0412000A (es) |
CA (1) | CA2530311A1 (es) |
MX (1) | MXPA05013958A (es) |
WO (1) | WO2005000292A1 (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06002393A (es) * | 2003-09-02 | 2006-06-20 | Novartis Ag | Tratamiento de cancer con epotilomas. |
EP1640004A1 (en) * | 2004-09-24 | 2006-03-29 | Schering Aktiengesellschaft | Use of epothilones in the treatment of bone metastases and bone tumors or cancers |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2775187B1 (fr) * | 1998-02-25 | 2003-02-21 | Novartis Ag | Utilisation de l'epothilone b pour la fabrication d'une preparation pharmaceutique antiproliferative et d'une composition comprenant l'epothilone b comme agent antiproliferatif in vivo |
US6302838B1 (en) * | 1998-02-25 | 2001-10-16 | Novartis Ag | Cancer treatment with epothilones |
JP2006504743A (ja) * | 2002-10-09 | 2006-02-09 | コーザン バイオサイエンシス インコーポレイテッド | 治療製剤 |
-
2004
- 2004-06-25 CA CA002530311A patent/CA2530311A1/en not_active Abandoned
- 2004-06-25 EP EP04740329A patent/EP1641449A1/en not_active Withdrawn
- 2004-06-25 US US10/561,757 patent/US20060205795A1/en not_active Abandoned
- 2004-06-25 WO PCT/EP2004/006921 patent/WO2005000292A1/en active Application Filing
- 2004-06-25 AU AU2004251444A patent/AU2004251444B2/en not_active Ceased
- 2004-06-25 BR BRPI0412000-0A patent/BRPI0412000A/pt not_active IP Right Cessation
- 2004-06-25 MX MXPA05013958A patent/MXPA05013958A/es not_active Application Discontinuation
- 2004-06-25 JP JP2006516063A patent/JP2009513486A/ja active Pending
- 2004-06-25 CN CNA2004800181891A patent/CN1812780A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2530311A1 (en) | 2005-01-06 |
JP2009513486A (ja) | 2009-04-02 |
US20060205795A1 (en) | 2006-09-14 |
EP1641449A1 (en) | 2006-04-05 |
AU2004251444A1 (en) | 2005-01-06 |
WO2005000292A1 (en) | 2005-01-06 |
BRPI0412000A (pt) | 2006-08-15 |
AU2004251444B2 (en) | 2008-05-22 |
CN1812780A (zh) | 2006-08-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200305126B (en) | Methods of administering epothilone analogs for the treatment of cancer. | |
AU2003245338A1 (en) | Plunger assembly for patient infusion device | |
AU2003244890A1 (en) | An infusion device for medical use. | |
HK1116339A1 (en) | Methods of administering epothilone analogs for the treatment of cancer | |
WO2007010273A3 (en) | Use of thiazole derivatives and analogues in the treatment of cancer | |
HK1111084A1 (en) | 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation | |
WO2004006859A3 (en) | Platinum compound | |
UA83798C2 (ru) | Применение эпотилонов в лечении заболеваний мозга, ассоциированных с пролиферативными процессами | |
AU2003243561A1 (en) | Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases | |
MY146794A (en) | Use of an alpha-2-delta ligand for the treatment of luts | |
AU2003294796A1 (en) | Epothilone analogs for site specific delivery in the treatment of proliferative diseases | |
HRP20121052T8 (en) | A medicament for the two-step perioperative therapy of solid tumours by radioimmunotherapy | |
HK1086493A1 (en) | Treatment of proliferative diseases with epothilone derivatives and radiation | |
MXPA05013958A (es) | Tratamiento de cancer con epotilona. | |
MXPA03006412A (es) | Metodos para administrar analogos de epotilona para tratamiento de cancer. | |
ZA200405342B (en) | The use of melagatran for the manufacture of a medicament for the treatment of type i diabetes mellitus | |
AU2003296545A1 (en) | Use of a trpm8-activating substance for the treatment of tumours | |
WO2005079769A3 (en) | Piperazine derivatives for the treatment of endometriosis | |
AU2002359635A1 (en) | Use of polycyclic phenolic compounds for the treatment of opthalmic diseases | |
AU2002335304A1 (en) | The use of berberine as insulin sensitizer | |
DE602004022578D1 (de) | Antitumorale terpen-verbindungen | |
AU2003296242A1 (en) | Thia-epothilone derivatives for the treatment of cancer | |
RS52038B (en) | USE OF 7-BUTOXYIMINOMETHYLAMPTOTECIN FOR THE TREATMENT OF NON-PLASMA NEOPLASMS | |
BRPI0415428A (pt) | formulações terapêuticas | |
AU2003216959A1 (en) | Derivatives of thiazoles used for the treatment of neurological diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |